Back |
home / stock / xene / xene message board
Subject | By | Source | When |
---|---|---|---|
Not the flyest numbers. -83.4% Rev growth, -334.68% | make it happen | investorshub | 10/04/2021 12:28:01 PM |
Good news but only phase 2. A long | make it happen | investorshub | 10/04/2021 12:25:35 PM |
30.24 | crudeoil24 | investorshub | 10/04/2021 12:15:13 PM |
Xenon Pharmaceuticals Reports Positive Phase 2b Result for | crudeoil24 | investorshub | 10/04/2021 11:36:40 AM |
Insider trade alert, but low volumes | diegonalesso | investorshub | 07/01/2017 12:28:26 PM |
On watch | Klinsmann | investorshub | 06/27/2017 6:02:55 PM |
I mean I think you could play today | Womack | investorshub | 03/24/2017 2:42:40 PM |
$3.50-$3.75 should be a nice area to get | TheInvincibleBull | investorshub | 03/24/2017 12:00:19 PM |
Xenon (NASDAQ:$XENE) has bucked the downward trend in | Dr_Thorfin | investorshub | 10/24/2016 7:56:26 AM |
Well, this is absolutely amazing! Opened at $9 | PharmaGreen007 | investorshub | 11/11/2014 12:42:05 AM |
News, Short Squeeze, Breakout and More Instantly...
Xenon Pharmaceuticals Inc. Company Name:
XENE Stock Symbol:
NASDAQ Market:
Xenon Pharmaceuticals Inc. Website:
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutic...
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver,...
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical ...